Bortezomib for Reduction of Proteinuria in IgA Nephropathy

INTRODUCTION: IgA nephropathy is the most common glomerulonephritis in the world. We conducted a pilot trial (NCT01103778) to test the effect of bortezomib in patients with IgA nephropathy and significant proteinuria. METHODS: We treated 8 consecutive subjects from July 2011 until March 2016 with 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartono, Choli, Chung, Miriam, Perlman, Alan S., Chevalier, James M., Serur, David, Seshan, Surya V., Muthukumar, Thangamani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035125/
https://www.ncbi.nlm.nih.gov/pubmed/29988921
http://dx.doi.org/10.1016/j.ekir.2018.03.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035125/
https://www.ncbi.nlm.nih.gov/pubmed/29988921
http://dx.doi.org/10.1016/j.ekir.2018.03.001

Ejemplares similares